INNOVADERM CRO IS NOW INDERO.

Effective Patient Recruitment Strategies for Clinical Trials: A Guide for Biotech and Pharmaceutical Sponsors

Patient recruitment is a critical component of successful clinical trials. Effective recruitment strategies ensure that trials are completed on time and that the data collected is robust. This article explores various strategies for recruiting patients, drawing insights from experienced professionals in the field, with a focus on what sponsors, biotech, and pharmaceutical companies need to […]

Early Phase Trials: More Than Just Safety

  Early phase clinical trials are no longer limited to assessing safety, they have become a foundation for strategic decision-making in drug development. Dr. Ana Palijan, Director of Early Phase and Translational Research at Indero, explores how these trials have evolved in scope and complexity. With over 25 years of experience in translational and early phase […]

Top Dermatology Conferences to Attend

The dermatology clinical research industry thrives on innovation, collaboration, and scientific advancements. Conferences are essential in nurturing these aspects, offering platforms for experts to exchange knowledge, discuss breakthroughs, and join forces to achieve the ultimate common goal: discovering new therapies and improving patients’ lives. Here, we highlight the top dermatology conferences that make significant contributions […]

Key Advantages of APAC for Sponsors

The Asia-Pacific (APAC) region is increasingly recognized as a strategic hub for global clinical research. With its vast and diverse patient populations, a blend of cost structures, and expanding government support, APAC offers unique advantages for sponsors seeking speed, scale, and efficiency. For clinical operations teams, success in APAC depends on understanding how to align […]

Interview with Dr. Robert Bissonnette: Indero Introduces New Early Phase 1 Model for Topical NCEs, Shortening Study Duration from 8-12 Weeks to ≀3 Days

  In this exclusive interview, Dr. Robert Bissonnette shares insights from Indero’s internally-led study, which introduces a novel approach to early phase topical drug evaluation. By leveraging quantitative gene expression analysis and non-invasive tape strip sampling, this method promises to transform the assessment of new chemical entities (NCEs), offering rapid, cost-effective, and patient-friendly solutions for […]

Innovative Approaches to Patient Recruitment in Clinical Trials

how to improve patient recruitment in clinical trials

Patient recruitment stands as a pivotal element that can determine the success or failure of a study. The effectiveness of patient recruitment directly impacts the quality and reliability of trial outcomes. This article will explore patient-centric approaches that prioritize the needs and experiences of patients, examine various strategies designed to boost recruitment rates, and highlight […]

The Role of Technology and Innovation in Clinical Trials: A Guide for Biotech and Pharma Sponsors

Technology and innovation are transforming the landscape of clinical trials, making them more efficient, accurate, and patient-centric. This article explores the key technological advancements and innovative practices of clinical trials, with a focus on what biotech, and pharmaceutical sponsors need to know.  Leveraging Artificial Intelligence and Digital Tools  Artificial Intelligence (AI) is revolutionizing clinical trials […]

Key Sessions to Attend at ACR Convergence 2025

The American College of Rheumatology (ACR) Convergence 2025, the world’s premier rheumatology experience, will take place October 24–29 in Chicago, Illinois. This year’s program offers a unique opportunity for clinical trial professionals and CRO teams to gain insights into protocol design, operational execution, and regulatory strategy in autoimmune research. Below is a curated list of sessions […]

Strengthening data integrity in trials with subjective endpoints

Clinical trials that rely on subjective or semi-subjective endpoints, such as clinician-reported outcomes or patient-reported symptoms, face distinct challenges when it comes to data integrity. This PharmaTimes Magazine article, written by Janet Overvelde, Indero’s Senior Director, Project Management, highlights some lessons learned in the dermatology field, which relies heavily on subjective outcomes, and outlines strategies […]

RTSM Optimization: Tips for Smooth Operations

Sponsor–Site Partnerships in Clinical Research

In this article, Veeva’s team joins us for a round table discussion on randomization and trial supply management (RTSM). We will tackle some of the most common mistakes in RTSM, share proactive steps to avoid these pitfalls, and explore real-life case studies with practical solutions. The discussion features insights from Kelly O’Brien, RTSM Senior Project […]

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.